Table 6. Secondary outcomes from interviews held at 12 months after intervention.
Intervention | Control | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | Mean | SD | N | Mean | SD | Adjusted mean difference | 95% CI for difference | P-value | Point estimate favours | ||
EQ-5D(quality of life) | Baseline | 54 | 0.74 | 0.32 | 56 | 0.76 | 0.24 | -0.04 | -0.12 to 0.04 | 0.357 | control |
12 months | 54 | 0.82 | 0.25 | 56 | 0.87 | 0.21 | |||||
AQ20(quality of life) | Baseline | 55 | 13.6 | 4.6 | 56 | 13.9 | 3.7 | -0.78 | -2.58 to -1.02 | 0.391 | Intervention |
12 months | 55 | 11.5 | 5.9 | 56 | 12.3 | 5.5 | |||||
North of England (symptoms) | Baseline | 133 | 13.3 | 5.4 | 131 | 13.5 | 5.1 | -0.04 | -1.16 to 1.09 | 0.949 | Intervention |
12 months | 133 | 9.9 | 5.0 | 131 | 10.1 | 4.2 | |||||
Asthma self-efficacy | Baseline | 129 | 5.7 | 2.1 | 131 | 5.9 | 1.9 | 0.25 | -0.13 to 0.63 | 0.188 | Intervention |
12 months | 129 | 6.4 | 1.8 | 131 | 6.3 | 1.6 |
In each model, the standard errors are adjusted for clustering by practice and for baseline value of outcome, BTS Step (3,4 or 5 vs. 1 or 2), number of GP partners, practice asthma admission rate, per cent of practice list that is south Asian and number of south Asians on practice list. SD is standard deviation